BUSINESS.fi updateAOP Orphan Pharmaceuticals Sweden AB, filial i Finland’s BUSINESS.fi Risk Grade has been published.The grade is B2.AOP Orphan Pharmaceuticals Sweden AB, filial i Finland13 Oct 2026Open risk grade